Chemical Dimerizers in Three-Hybrid Systems for Small Molecule–Target Protein Profiling

2016 ◽  
Vol 11 (8) ◽  
pp. 2075-2090 ◽  
Author(s):  
Dries J. H. De Clercq ◽  
Jan Tavernier ◽  
Sam Lievens ◽  
Serge Van Calenbergh
RSC Advances ◽  
2018 ◽  
Vol 8 (68) ◽  
pp. 38758-38764
Author(s):  
Jianwei Zhao ◽  
Cuiping Li ◽  
Guimin Ma ◽  
Wenhui Hao ◽  
Hongxia Jia

A novel colorimetric strategy for protein detection was developed based on unmodified gold nanoparticles (AuNPs) and terminal protection from a target protein.


ChemMedChem ◽  
2014 ◽  
Vol 10 (2) ◽  
pp. 296-303 ◽  
Author(s):  
Duncan E. Scott ◽  
Anthony G. Coyne ◽  
Ashok Venkitaraman ◽  
Tom L. Blundell ◽  
Chris Abell ◽  
...  

2002 ◽  
Vol 63 (9) ◽  
pp. 1619-1628 ◽  
Author(s):  
Debbie C. Henthorn ◽  
Albert A. Jaxa-Chamiec ◽  
Eric Meldrum

Biosensors ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 451
Author(s):  
Ping Ouyang ◽  
Chenxin Fang ◽  
Jialun Han ◽  
Jingjing Zhang ◽  
Yuxing Yang ◽  
...  

The qualitative and quantitative determination of marker protein is of great significance in the life sciences and in medicine. Here, we developed an electrochemical DNA biosensor for protein detection based on DNA self-assembly and the terminal protecting effects of small-molecule-linked DNA. This strategy is demonstrated using the small molecule biotin and its receptor protein streptavidin (SA). We immobilized DNA with a designed structure and sequence on the surface of the gold electrode, and we named it M1-Biotin DNA. M1-Biotin DNA selectively combines with SA to generate M1-Biotin-SA DNA and protects M1-Biotin DNA from digestion by EXO III; therefore, M1-Biotin DNA remains intact on the electrode surface. M1-Biotin-SA DNA was modified with methylene blue (MB); the MB reporter molecule is located near the surface of the gold electrode, which generates a substantial electrochemical signal during the detection of SA. Through this strategy, we can exploit the presence or absence of an electrochemical signal to provide qualitative target protein determination as well as the strength of the electrochemical signal to quantitatively analyze the target protein concentration. This strategy has been proven to be used for the quantitative analysis of the interaction between biotin and streptavidin (SA). Under optimal conditions, the detection limit of the proposed biosensor is as low as 18.8 pM, and the linear range is from 0.5 nM to 5 μM, showing high sensitivity. The detection ability of this DNA biosensor in complex serum samples has also been studied. At the same time, we detected the folate receptor (FR) to confirm that this strategy can be used to detect other proteins. Therefore, this electrochemical DNA biosensor provides a sensitive, low-cost, and fast target protein detection platform, which may provide a reliable and powerful tool for early disease diagnosis.


BIO-PROTOCOL ◽  
2020 ◽  
Vol 10 (3) ◽  
Author(s):  
Kruthi Suvarna ◽  
Kaori Honda ◽  
Makoto Muroi ◽  
Yasumitsu Kondoh ◽  
Nobumoto Watanabe ◽  
...  

2020 ◽  
pp. 247255522097535
Author(s):  
Anders Gunnarsson ◽  
Christopher J. Stubbs ◽  
Philip B. Rawlins ◽  
Eleanor Taylor-Newman ◽  
Wei-chao Lee ◽  
...  

A key activity in small-molecule drug discovery is the characterization of compound–target interactions. Surface plasmon resonance (SPR) is a flexible technique for this purpose, with a wide affinity range (micromoles to picomoles), low protein requirements, and the ability to characterize the kinetics of compound binding. However, a key requirement of SPR is the immobilization of the target protein to the surface of the sensor chip. The most commonly used immobilization techniques (covalent immobilization, streptavidin–biotin) are irreversible in nature, which can afford excellent baseline stability but impose limitations throughput for slowly dissociating compounds or unstable targets. Reversible immobilization (e.g., His-tag–Ni-NTA) is possible but typically precludes accurate quantification of slow dissociation kinetics due to baseline drift. Here we present our investigation of three immobilization strategies (dual-His-tagged target protein, His-tagged streptavidin, and switchavidin) that combine the robustness of irreversible immobilization with the flexibility of reversible immobilization. Each has its own advantages and limitations, and while a universal immobilization procedure remains to be found, these strategies add to the immobilization toolbox that enables previously out-of-scope applications. Such applications are highlighted in two examples that greatly increased throughput for the kinetic characterization of potent kinase inhibitors and kinetic profiling of covalent inhibitors.


2020 ◽  
Vol 16 (9) ◽  
pp. 997-1005 ◽  
Author(s):  
Bernard P. Kok ◽  
Srijana Ghimire ◽  
Woojoo Kim ◽  
Shreyosree Chatterjee ◽  
Tyler Johns ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document